High dose oral rifampicin to improve survival from adult tuberculous meningitis: A randomised placebo-controlled double-blinded phase III trial (the HARVEST study).

Marais, Suzaan; Cresswell, Fiona V; Hamers, Raph L; Te Brake, Lindsey HM; Ganiem, Ahmad R; Imran, Darma; Bangdiwala, Ananta; Martyn, Emily; Kasibante, John; Kagimu, Enock; +16 more... Musubire, Abdu; Maharani, Kartika; Estiasari, Riwanti; Kusumaningrum, Ardiana; Kusumadjayanti, Nadytia; Yunivita, Vycke; Naidoo, Kogieleum; Lessells, Richard; Moosa, Yunus; Svensson, Elin M; Huppler Hullsiek, Katherine; Aarnoutse, Rob E; Boulware, David R; van Crevel, Reinout; Ruslami, Rovina; Meya, David B; (2019) High dose oral rifampicin to improve survival from adult tuberculous meningitis: A randomised placebo-controlled double-blinded phase III trial (the HARVEST study). Wellcome open research, 4. p. 190. ISSN 2398-502X DOI: https://doi.org/10.12688/wellcomeopenres.15565.2

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.12688/wellcomeopenres.15565.2

Abstract

Item Type Article
Faculty and Department Faculty of Infectious and Tropical Diseases > Dept of Clinical Research
PubMed ID 33083560
Elements ID 141926

Share

Download

Filename: High dose oral rifampicin to improve survival from adult tuberculous meningitis A randomised placebo-controlled double-blind.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar